Jubilant Pharmova Limited
Share Price Target & Analysis
NSE:JUBLPHARMA
VWAP
Open
Close
High
Low
52 Week High
21.25 (2.13%)
JUBLPHARMA
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: JUBLPHARMA Share Price Financial Analysis & Valuation
Jubilant Pharmova Limited (JUBLPHARMA) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Small Cap company with Market Capitalization of Rs 8364 (in Cr). Total number of free float shares are 0 (in Lacs).
Jubilant Pharmova Limited is listed on NSE with Exchange ID - INE700A01033 and trading code is NSE:JUBLPHARMA with short name Jubilant Pharmo.
In the past 1 year, Jubilant Pharmova Limited has declared an equity dividend of Rs 0.49 per share. At the current share price of JUBLPHARMA at Rs 1019.00, this results in a dividend yield of 0.05 %.
As per the Fundamental Analysis of NSE:JUBLPHARMA, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JUBLPHARMA underlying value and future prospects. All of this data is available in JUBLPHARMA financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:JUBLPHARMA, it is clearly understood that JUBLPHARMA is Economical performer in terms of earnings and profit margins with an EPS of 4.35. NSE:JUBLPHARMA book value per share as of today is 145.63. The current price to book ratio for JUBLPHARMA as of Sep 09, 2026 is 7.
Valuation of the Stock: The current valuation of JUBLPHARMA stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JUBLPHARMA whether to BUY this stock at current valuation. The delivery percentage of JUBLPHARMA is 287224% is very crucial parameter which shows that 287224% investors are anticipating that the price of JUBLPHARMA share should go up with VWAP at 1006.28.
Now, the main question is whether to BUY or SELL, NSE:JUBLPHARMA at current valuation.
As per latest Analysis No. #2190:-
⇑ STRONG BUY JUBLPHARMA if All Greens
⇗ BUY JUBLPHARMA (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD JUBLPHARMA (With Stop Loss) if only 1 Green
⇘ SELL JUBLPHARMA if NO Green Indicator
NSE: JUBLPHARMA Share Price Today (Sep 09, 2026)
(Jubilant Pharmova Limited Daily Analysis on the basis of JUBLPHARMA Intraday Graph & Trend)
Jubilant Pharmova Limited share price moved Up by 2.13% from its previous close of Rs 997.75. JUBLPHARMA stock last traded price is 1019.00. JUBLPHARMA share price trend is Up with a total of 452808 stocks traded till now. It has touched an intraday high of Rs 1023.5 and an intraday low of Rs 989.05. The JUBLPHARMA trading at 1019.00, Up by Rs. 21.25, or 2.13 percent which suggests that most of the Traders are anticipating that the price of JUBLPHARMA share should go Up.
NSE: JUBLPHARMA Share Price Tomorrow Prediction
(Jubilant Pharmova Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JUBLPHARMA)
Jubilant Pharmova Limited share price moved Up by 2.13%. JUBLPHARMA share price short term trend is Up. It suggests that JUBLPHARMA Share Price for Tomorrow remains the same with VWAP at 1006.28 will be treated as stop loss for intraday traders. Jubilant Pharmova Limited Long term investors can follow the JUBLPHARMA long term trend as mentiond in future forecast table.
NSE Code |
NSE: JUBLPHARMA |
JUBLPHARMA Share Price Today |
1019.00 |
JUBLPHARMA Share Price Target Prediction for 2026 ^ |
946.9 - 1190.7 |
JUBLPHARMA Share Price Target Prediction for 2027*^ |
1190.7 - 1268.4 |
JUBLPHARMA Share Price Target Prediction for 2028*^ |
1268.4 - 1357.2 |
JUBLPHARMA Share Price Target Prediction for 2029*^ |
1425 |
JUBLPHARMA Share Price Target Prediction for 2030*^ |
1466 |
JUBLPHARMA Share Price Target Prediction for 2035*^ |
1598 |
| JUBLPHARMA Current Book Value |
144.9 |
*Jubilant Pharmova Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JUBLPHARMA share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
JUBLPHARMA Technical Analysis
Candlestick Pattern: @907.6| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 887.65 | BUY | 891.58 | BUY |
| MA_12 | 881.21 | BUY | 893.09 | BUY |
| MA_20 | 897.38 | BUY | 901.56 | BUY |
| MA_32 | 930.32 | SELL | 917.33 | SELL |
| MA_50 | 944.49 | SELL | 928.35 | SELL |
| MA_100 | 959.15 | SELL | 941.01 | SELL |
| MA_200 | 965.6 | SELL | 968.26 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 897.38 | Uptrend |
| MACD | 3.81 | BUY |
| ADX | 12.71 | NO or Weak Trend |
| DMI (+/-) | 19.66 / 17.17 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 49.13 | Neutral |
| STOCHASTIC_K (Fast) | 69.86 | Neutral |
| STOCHASTIC_D (Slow) | 38.07 | Neutral |
| CCI | 99.87 | Neutral |
| PSAR | 847.85 | BUY |
| TRUE RANGE | 41.15 | SELL |
| ATR | 31.14 | SELL |
| WILLIAMS R | -25.59 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 100 | Overbought |
| STOCHASTIC RSI D | 52.16 | Neutral |
| MOMENTUM | -25.55 | SELL |
| Duration | Value |
|---|---|
| 1 Year | -12.92% |
| 3 Months | -8.1% |
| 1 Month | -2.74% |
| 1 Week | 1.22% |
| Action | Overall (%) |
|---|---|
| BUY | 37% |
| NEUTRAL / HOLD | 27% |
| SELL | 37% |
Most popular Questions & Answers about JUBLPHARMA (/ FAQ JUBLPHARMA)
Jubilant Pharmova Limited stock last traded price is 1019.00. JUBLPHARMA share price moved Up by 2.13% from its previous close of Rs 997.75.
Jubilant Pharmova Limited share price trend is Up with a total of 452808 stocks traded till now. It has touched an intraday high of Rs 1196.648 and an intraday low of Rs 989.05. The JUBLPHARMA trading at 1019.00, Up by Rs. 21.25, or 2.13 percent which suggests that most of the Traders are anticipating that the price of JUBLPHARMA share should go Up and the Stop Loss will be around 1006.28.
The market cap of Jubilant Pharmova Limited is ₹8364 (in Cr) as of Sep 08, 2026.
The current price to earning ratio for Jubilant Pharmova Limited as of Sep 08, 2026 is 250.99.
The current price to book ratio for Jubilant Pharmova Limited as of Sep 08, 2026 is 7.
The highest price of Jubilant Pharmova Limited stock is ₹1184.8 in the last 52-week.
The lowest price of Jubilant Pharmova Limited stock is ₹786.05 in the last 52-week.
Jubilant Pharmova Limited share trading at ₹1019.00, Up by Rs. 21.25, or 2.13 percent which suggests that most of the traders are anticipating that the price of JUBLPHARMA share should go Up.
In 2026, Stock price target for Jubilant Pharmova Limited (JUBLPHARMA) will be around ₹946.9 on downside and ₹1190.7 on upside. Jubilant Pharmova Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Jubilant Pharmova Limited (JUBLPHARMA) will be around ₹1190.7 on downside and ₹1268.4 on upside. Jubilant Pharmova Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Jubilant Pharmova Limited (JUBLPHARMA) will be around ₹1268.4 on downside and ₹1357.2 on upside. Jubilant Pharmova Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Jubilant Pharmova Limited (JUBLPHARMA) will be around ₹1466 Jubilant Pharmova Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JUBLPHARMA.
The price of Jubilant Pharmova Limited (JUBLPHARMA) shares moved by 2.13%. The short-term trend for JUBLPHARMA share price is Up. It implies that the share price of JUBLPHARMA will stay the same tomorrow and that intraday traders should treat VWAP at 1006.28 as a stop loss. Investors with a long-term outlook can track JUBLPHARMA long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of JUBLPHARMA stock is 52.2. Compared to the current market price of 1019.00 INR, the JUBLPHARMA stock is Overvalued by 94.9%.
As per the fundamental analysis of Jubilant Pharmova Limited (JUBLPHARMA), it is of Economical quality in terms of earnings and profit margins with an EPS of 4.35. Jubilant Pharmova Limited book value per share as of today is 145.63. The current price to book ratio for JUBLPHARMA as of Sep 09, 2026 is 7.
NSE:JUBLPHARMA News & Other Useful Information about JUBLPHARMA Share Price
Peer Comparison of NSE: JUBLPHARMA
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1864.90 | 16.35 | 97.89 |
| DIVISLAB | 9488.00 | 115.55 | 663.06 |
| MEDICAMEQ | 291.50 | 12.15 | 208.08 |
| CIPLA | 1363.10 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4930.00 | 87.32 | 235.7 |
| BIOCON | 395.00 | 1.27 | 166.51 |
| LUPIN | 2100.00 | 154.86 | 718.37 |
| ALKEM | 5139.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1698.90 | 46.49 | 403.84 |
| ABBOTINDIA | 25225.00 | 766.11 | 2448.41 |
| GLAXO | 2890.20 | 63.65 | 147.25 |
| IPCALAB | 1963.60 | 56.72 | 329.23 |
| LAURUSLABS | 1937.00 | 20.74 | 102.57 |
| LALPATHLAB | 1919.70 | 39.68 | 157.23 |
| PFIZER | 4171.00 | 170.54 | 963.41 |
| AJANTPHARM | 3534.40 | 89.3 | 363.23 |
| SANOFI | 3104.20 | 158.05 | 332.96 |
| NATCOPHARM | 826.30 | 82.14 | 481.67 |
| APLLTD | 817.40 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2435.00 | 1.24 | 881.78 |
| AAREYDRUGS | 98.01 | 2.39 | 53.38 |
| JUBLPHARMA | 1019.00 | 4.35 | 145.63 |
| SPARC | 200.58 | 48.14 | 40.45 |
| GRANULES | 884.80 | 23.25 | 180.42 |
| ASTRAZEN | 6876.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2723.10 | 55.52 | 285.6 |
| FDC | 354.30 | 21.19 | 161.21 |
| HIKAL | 240.69 | 9.34 | 96.63 |